@article{07134d144b9340ae91ec71f04238a885,
title = "Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab",
abstract = "The study aim was to compare European Organization for Research and Treatment of Cancer (EORTC) criteria with PET Response Criteria in Solid Tumors (PERCIST) for response evaluation of patients with metastatic colorectal cancer treated with a combination of the chemotherapeutic drug irinotecan and the monoclonal antibody cetuximab.",
keywords = "Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bone Neoplasms, Camptothecin, Colorectal Neoplasms, Denmark, Digestive System Neoplasms, Female, Fluorodeoxyglucose F18, Humans, Image Interpretation, Computer-Assisted, Lung Neoplasms, Lymphatic Metastasis, Male, Middle Aged, Outcome Assessment (Health Care), Positron-Emission Tomography and Computed Tomography, Prevalence, Radiopharmaceuticals, Reproducibility of Results, Risk Assessment, Sensitivity and Specificity, Survival Analysis, Survival Rate, Treatment Outcome",
author = "Kristin Skougaard and Dorte Nielsen and Jensen, {Benny Vittrup} and Hendel, {Helle Westergren}",
year = "2013",
month = jul,
doi = "10.2967/jnumed.112.111757",
language = "English",
volume = "54",
pages = "1026--31",
journal = "Journal of nuclear medicine : official publication, Society of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "7",
}